United Kingdom · Question · Written question
UIN 56072
Blood Cancer: Drugs
Introduced
8 June 2020
Last action
24 June 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
24 June 2020
Summary
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that NICE recommendations for newly licensed medicines for (a) blood cancer and (b) multiple myeloma are not delayed as a result of the covid-19 pandemic.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 June 2020
Written question
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that NICE recommendations for newly licensed medicines for (a) blood cancer and (b) multiple myeloma are not delayed as a result of the covid-19 pandemic.
Source: Commons
24 June 2020
Answer
In response to the COVID-19 pandemic, the National Institute for Health and Care Excellence (NICE) adapted its priorities to support the National Health Service, local authorities and the wider health and social care sector. In March, NICE paused the publ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-06-08/56072
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1201407
- uk · wq-1201407 · source updated 24 June 2020